N-(tert-Butyl)-3-nitro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide

Catalog No. :
ACQTYS186
CAS No. :
1309980-13-9
Molecular Formula :
C17H25BN2O5
Molecular Weight :
348.21

IUPAC Name:N-(tert-butyl)-3-nitro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide

N-(tert-Butyl)-3-nitro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$462.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(tert-Butyl)-3-nitro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide
IUPAC NameN-(tert-butyl)-3-nitro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide
Molecular FormulaC17H25BN2O5
Molecular Weight348.21
SMILESO=C(NC(C)(C)C)C1=CC(B2OC(C)(C)C(C)(C)O2)=CC([N+]([O-])=O)=C1
InChI KeyMOGJLCAUYCKDQQ-UHFFFAOYSA-N
SynonymBenzaMide, N-(1,1-diMethylethyl)-3-nitro-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-
CAS No.1309980-13-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACQTYS186 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPLCQ651 route compound structure diagram
    ACPLCQ65160469-70-7
  2. Plus
  3. ACWFBJ784 route compound structure diagram
    ACWFBJ784377780-80-8 In Stock
  4. Then
  5. ACQTYS186 route product structure diagram
    ACQTYS1861309980-13-9
Inquiry

2. ACQTYS186 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  4. Then
  5. ACQTYS186 route product structure diagram
    ACQTYS1861309980-13-9
Inquiry

Comments (0)